ALB and small cell lung carcinoma: Wang et al. shows that nanoparticle albumin combined with paclitaxel is safe and effective in the third-line treatment of recurrent SCLC [16], and Eiff et al.’s research shows that paclitaxel has clinically relevant activity in heavily pretreated SCLC [17].